K V Kasyanenko

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Candida Albicans

Squamous Cell Carcinoma

Top Venues

Terapevticheskii arkhiv

This page only lists publications with an associated author ORCID identifier.

Publications

O V Maltsev, K V Kasyanenko, K V Zhdanov, N A Malyshev, E V Kolomoets, V K Konomou
[The experience in treatment of dengue fever using antiviral drug riamilovir in the Republic of Guinea (case report)]. Terapevticheskii arkhiv 95 (1) (2023)
O V Maltsev, K V Kasyanenko, K V Zhdanov, N A Malyshev, E V Kolomoets, V K Konomou
[The experience in treatment of dengue fever using antiviral drug riamilovir in the Republic of Guinea (case report)]. Terapevticheskii arkhiv 95 (1) (2023)
O V Maltsev, K V Kasyanenko, K V Zhdanov, N A Malyshev, E V Kolomoets, V K Konomou
[The experience in treatment of dengue fever using antiviral drug riamilovir in the Republic of Guinea (case report)]. Terapevticheskii arkhiv 95 (1) (2023)
K V Zhdanov, O V Maltsev, K V Kasyanenko, K V Kozlov, V S Sukachev, N I Lvov, V V Sharabkhanov, A A Litvinov
[Clinical efficiency and safety of riamilovir under various dosage regimens for treatment of acute respiratory viral infections in adults]. Terapevticheskii arkhiv 95 (11) (2023)
K V Zhdanov, O V Maltsev, K V Kasyanenko, K V Kozlov, V S Sukachev, N I Lvov, V V Sharabkhanov, A A Litvinov
[Clinical efficiency and safety of riamilovir under various dosage regimens for treatment of acute respiratory viral infections in adults]. Terapevticheskii arkhiv 95 (11) (2023)
O V Maltsev, K V Kasyanenko, K V Kozlov, K V Zhdanov, I I Lapikov
Prospects of using the nucleoside analogue riamilovir in patients with SARS-CoV-2 infection. Terapevticheskii arkhiv 94 (10) (2022)
K V Kasyanenko, K V Kozlov, O V Maltsev, I I Lapikov, V V Gordienko, V V Sharabkhanov, P V Sorokin, K V Zhdanov
[Evaluation of the effectiveness of Riamilovir in the complex therapy of patients with COVID-19]. Terapevticheskii arkhiv 93 (3) (2021)